Sotac Pharmaceuticals Ltd Company History and Annual Growth Details

The Company was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 (“Partnership Act”) in the name and style of “M/s Sotac Pharmaceuticals”, pursuant to a deed of partnership dated October 28, 2015. Thereafter "M/s. Sotac Pharmaceuticals” was converted from Partnership Firm to a Private Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of “Sotac Pharmaceuticals Private Limited” and received a certificate of incorporation dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat. Later on the Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of the Company held on November 12, 2022 and the name of the Company was changed to “Sotac Pharmaceuticals Limited”. A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated November 22, 2022 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company is U24230GJ2015PLC085451.

MAJOR EVENTS :

2015

- The Company was incorporated as a private limited company under the name “Sotac Pharmaceuticals Private Limited” Limited”.

2019

- Recognised as “Fastest Growing Indian Company” with and Excellence Award by International Achievers Conference

2021

- Received “Indo Global award for Business Excellence”

2022

- The Company has acquired 53,25,000 Equity Shares in SOTAC Healthcare Private Limited making it subsidiary of the Company.

- The Company has acquired 99,995 Equity Shares in SOTAC Research Private Limited making it wholly owned subsidiary of the Company.

- The Company was converted into Public Limited Company under the name of “Sotac Pharmaceuticals Limited”

- Received recognition as for “Fastest Expansion of Project” by Sanand Industries Association (SIA)

- Recognized as one of the “Top 10 Pharma Contract Manufacturers in India” by India Pharma Outlook

2024

-The Company has received Letter of Acceptance of Approx. Rs. 17,13,01,433/ from Rajasthan Medical Services Corporation Ltd. for supply of various Pharmaceuticals products.

2025

-The Company has received  Purchase Order from Cadila Pharmaceuticals Limited amounting of Rs. 1,73,55,534/- for supply of Levozet M Tablet.

-The Company has received a new work order from Rajasthan Medical Services Corporation Ltd. for supply of pharmaceuticals products of Rs. 27,63,89,634/.